Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2016 | 1 |
2017 | 2 |
2019 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
N Engl J Med. 2016.
PMID: 27295427
Free PMC article.
Clinical Trial.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.
Gerstein HC, et al.
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
Lancet. 2019.
PMID: 31189511
Clinical Trial.
Item in Clipboard
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.
Mann JFE, et al.
N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.
N Engl J Med. 2017.
PMID: 28854085
Free article.
Clinical Trial.
Item in Clipboard
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.
Gerstein HC, et al.
Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.
Lancet. 2019.
PMID: 31189509
Clinical Trial.
Item in Clipboard
Predictors of hearing technology use in children.
Booysen S, le Roux T, Masenge A, Swanepoel W.
Booysen S, et al.
Int J Audiol. 2022 Apr;61(4):336-343. doi: 10.1080/14992027.2021.1913521. Epub 2021 May 13.
Int J Audiol. 2022.
PMID: 33983867
Item in Clipboard
Parasites of domestic and wild animals in South Africa. L. Ixodid ticks infesting horses and donkeys.
Horak IG, Heyne H, Halajian A, Booysen S, Smit WJ.
Horak IG, et al. Among authors: booysen s.
Onderstepoort J Vet Res. 2017 Feb 28;84(1):e1-e6. doi: 10.4102/ojvr.v84i1.1302.
Onderstepoort J Vet Res. 2017.
PMID: 28281774
Free PMC article.
Item in Clipboard
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators.
Steg PG, et al.
Eur Heart J. 2011 Oct;32(20):2541-54. doi: 10.1093/eurheartj/ehr334. Epub 2011 Aug 30.
Eur Heart J. 2011.
PMID: 21878434
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite